Truscreen Group Share Price and Company Fundamentals
Last traded: Yesterday at 11:20 PM
TruScreen Group Limited, together with its subsidiaries, develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, and the Middle East/North Africa. It offers the TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time. The company was formerly known as TruScreen Limited and changed its name to Truscreen Group Limited in August 2020. TruScreen Group Limited was incorporated in 2013 and is headquartered in Auckland, New Zealand.
Key Metrics
PE ratio
-
PB ratio
3.47
Dividend yield
-
Beta
-0.13
Market cap
$11.21M
Enterprise value
$9.23M
Company profile
| Industry / Sector | Medical Devices / Healthcare |
|---|---|
| Website | https://truscreen.com |
| Mailing address | Equitable House Level 6 57 Symonds Street Grafton Auckland 1010 New Zealand |
| Phone / Fax | / |
Dividends
More: Truscreen Group Dividend history, yield and payout ratio
Dividend yield
-
Dividend amount
$-
Payout ratio
0.00%
5Y Avg. yield
-%
Truscreen Group paid $- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.TRU dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Truscreen Group.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Martin Dillon | Chief Executive Officer | ||
| Mr. Guy Adrian Robertson B.Com., B.Comm(Hons.), CA, MAICD | CFO & Company Secretary | 72 | |
| Dr. . Phunc | Head of Cancer Department | ||
| Dr. . Chuong | Head of Research & Development and Training Department | ||
| Dr. . Thuy | Head of High Service Gynaecology Examination |
Profitability and management effectiveness
Profit margin
-135.50%
Operating margin
-113.53%
Return on assets
-35.39%
Return on equity
-90.84%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Truscreen Group is 11.21M and its enterprise value is 9.23M. The enterprise value to revenue ratio of TRU is 5.07. The enterprise value to EBITDA ratio of TRU is -.
Companies similar to Truscreen Group (TRU)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Pro Medicus (PME)
- Polynovo (PNV)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Truscreen Group (ASX:TRU) Frequently Asked Questions
1. What is Truscreen Group's Stock Symbol?
Truscreen Group trades on ASX under the ticker symbol "TRU".
2. What is Truscreen Group's stock price today?
One share of TRU stock can currently be purchased for approximately $0.015.
3. How can I contact Truscreen Group?
Truscreen Group's mailing address is Equitable House Level 6 57 Symonds Street Grafton Auckland 1010 New Zealand. The company can be reached via phone at .
4. What is Truscreen Group's official website?
The official website of Truscreen Group is https://truscreen.com.